Atlas Trials

The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib)

Clinical trial NCT03694262 · COMPLETED

Trial details

NCT number
NCT03694262
Sponsor
Medical College of Wisconsin
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrial CancerUterine Carcinosarcoma
Start date
2019-07-19
Primary completion
2023-03-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.